EISAI CO LTD (ESALF:OTCMKTS)
$29 0 (0%)
Analysed EISAI CO LTD (ESALF:OTCMKTS) News Sources
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
31-08-2026
yahoo.com
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
03-09-2026
yahoo.com
Biogen (BIIB) Brings At Home Weekly Alzheimer’s Injection To U.S. Patients
03-09-2026
yahoo.com
Why the CNS boom owes its success to breakthroughs in neurological pathologies
08-09-2026
pharmaceutical-technology.com
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
15-09-2026
yahoo.com
Leqembi® Pen subcutaneous formulation approved in Japan
16-09-2026
yahoo.com
How Investors May Respond To Biogen (BIIB) Advancing At-Home LEQEMBI Pen And Kidney Disease Data
23-09-2026
yahoo.com
Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?
28-09-2026
yahoo.com
FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication
28-09-2026
yahoo.com
eClinical Solutions Turns Clinical Data Intelligence Into Action at ENGAGE 2026
08-10-2026
yahoo.com
What is the current price of EISAI CO LTD (ESALF:OTCMKTS)?
The current price of EISAI CO LTD (ESALF:OTCMKTS) is $29.
EISAI CO LTD (ESALF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of EISAI CO LTD (ESALF:OTCMKTS) since the previous trading day is $0.
EISAI CO LTD (ESALF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of EISAI CO LTD (ESALF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for EISAI CO LTD (ESALF:OTCMKTS)?
The most recent average sentiment score for EISAI CO LTD (ESALF:OTCMKTS) is 69 out of 100.
What is the most recent average sentiment for EISAI CO LTD (ESALF:OTCMKTS)?
The most recent sentiment for EISAI CO LTD (ESALF:OTCMKTS) is .
SEC-8K** Filing Available For EISAI CO LTD (ESALF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.